Bluepha secures USD66.48 million series B2 financing round
On 9 Aug., Beijing Bluepha Microbiology Technology Co., Ltd. (Bluepha), a synthetic biology leader in China, announced that it had secured USD66.48 million (RMB430 million) in a series B2 financing round led by several famous investors. Over the past...
Bio-based Material Quarterly Newsletter Q3 2021